This comes after President said in interview with Fox News' Sean Hannity that Medicare and Medicaid would be "untouched."

The court filing was made in a case brought by Novartis, one of nearly a dozen large pharmaceutical companies that have filed lawsuits challenging Medicare negotiations even as the effort proceeds. As with the other drugmakers,

Dr. Memhet Oz will have to divest millions of dollars in healthcare stocks and investments if he is confirmed as President Donald Trump's head of the Centers for Medicare and Medicaid Services, according to a government ethics report.

U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy benefit managers (PBMs),

Medicare Advantage is continuing to bulk up its lobbying efforts, with the Better Medicare Alliance finding itself among 10 new clients signed by Squire Patton Boggs.

The TV celebrity and Trump nominee has pledged to divest from most of his financial interests. But they touch nearly every corner of health care, from insurance to blood pressure cuffs and vitamins, leading experts and lawmakers to doubt he could make impartial decisions.

The industry could see payment, workforce and insurance coverage changes depending on how the Trump administration weighs in on several federal lawsuits.

As mentioned in previous columns, HSAs offer a triple tax break in that contributions are deductible, the account grows tax-deferred and withdrawals are tax-free for qualifying medical expenses. Those expenses can include dental and vision costs as well as Medicare premiums.